Phase IIa Study for IPG11406 in Patients With Lupus Nephritis

Clinical trial NCT06717815 · RECRUITING

Trial details

NCT number: NCT06717815
Sponsor: Nanjing Immunophage Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2025-02-25
Primary completion: 2026-04-22
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.